Clinical Trial Update: A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing PF-06410293 (adalimumab-Pfizer) to adalimumab (Humira), both with methotrexate, in active rheumatoid arthritis has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Adalimumab-Pfizer (adalimumab)
• Humira (adalimumab)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-09-26